- Supported exchanges /
- TWO /
- 6586.TWO
CHO Pharma Inc. (6586 TWO) stock market data APIs
CHO Pharma, Inc., a biopharmaceutical company, develops and commercializes therapeutic and diagnostic products for the unmet clinical needs. It is developing homogeneous antibody drugs, such as CHO-H01, CHO-H02, and CHO-A04, a humanized monoclonal antibody for cancer; CHO-H03, a homogeneous antibody drug for autoimmune diseases; CHO-S05 dual-effect anti-flu drugs; and CHO-V08 for Klebsiella pneumonia. The company was founded in 2012 and is based in Taipei City, Taiwan.
CHO Pharma Inc. Financial Data Overview
55.6 | |
56 | |
- | |
56 | |
55.2 | |
51.7-80.6 | |
11 899 M | |
214 M | |
1 082 K | |
0.072 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
CHO Pharma Inc. Fundamental Data is available in our Financial Data APIs
- Net Revenue 1 082 K
- EBITDA -217 206 000
- Earnings Per Share -1.25
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get CHO Pharma Inc. Earnings via APIs
- Latest Release NaN
- EPS/Forecast NaN
Get CHO Pharma Inc. End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: